Cargando…

SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses

Detalles Bibliográficos
Autores principales: Zhu, Yuanmei, Yu, Danwei, Hu, Yue, Wu, Tong, Chong, Huihui, He, Yuxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330190/
https://www.ncbi.nlm.nih.gov/pubmed/34344868
http://dx.doi.org/10.1038/s41392-021-00698-x
_version_ 1783732652860243968
author Zhu, Yuanmei
Yu, Danwei
Hu, Yue
Wu, Tong
Chong, Huihui
He, Yuxian
author_facet Zhu, Yuanmei
Yu, Danwei
Hu, Yue
Wu, Tong
Chong, Huihui
He, Yuxian
author_sort Zhu, Yuanmei
collection PubMed
description
format Online
Article
Text
id pubmed-8330190
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-83301902021-08-04 SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses Zhu, Yuanmei Yu, Danwei Hu, Yue Wu, Tong Chong, Huihui He, Yuxian Signal Transduct Target Ther Letter Nature Publishing Group UK 2021-08-03 /pmc/articles/PMC8330190/ /pubmed/34344868 http://dx.doi.org/10.1038/s41392-021-00698-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
Zhu, Yuanmei
Yu, Danwei
Hu, Yue
Wu, Tong
Chong, Huihui
He, Yuxian
SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses
title SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses
title_full SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses
title_fullStr SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses
title_full_unstemmed SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses
title_short SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses
title_sort sars-cov-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330190/
https://www.ncbi.nlm.nih.gov/pubmed/34344868
http://dx.doi.org/10.1038/s41392-021-00698-x
work_keys_str_mv AT zhuyuanmei sarscov2derivedfusioninhibitorlipopeptidesexhibithighlypotentandbroadspectrumactivityagainstdivergenthumancoronaviruses
AT yudanwei sarscov2derivedfusioninhibitorlipopeptidesexhibithighlypotentandbroadspectrumactivityagainstdivergenthumancoronaviruses
AT huyue sarscov2derivedfusioninhibitorlipopeptidesexhibithighlypotentandbroadspectrumactivityagainstdivergenthumancoronaviruses
AT wutong sarscov2derivedfusioninhibitorlipopeptidesexhibithighlypotentandbroadspectrumactivityagainstdivergenthumancoronaviruses
AT chonghuihui sarscov2derivedfusioninhibitorlipopeptidesexhibithighlypotentandbroadspectrumactivityagainstdivergenthumancoronaviruses
AT heyuxian sarscov2derivedfusioninhibitorlipopeptidesexhibithighlypotentandbroadspectrumactivityagainstdivergenthumancoronaviruses